These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33449527)

  • 1. [Comparison of the efficacy of Cellex and Cortexin in patients in the early recovery period of ischemic stroke].
    Khabirov FA; Khaibullin TI; Granatov EV; Akhmetova GI; Akhmetzyanov NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):11-15. PubMed ID: 33449527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the efficacy and safety of application of the drug cortexin in the complex rehabilitation of verticalization in patients with ischemic stroke in the acute period].
    Mashin VV; Belova LA; Aizatullin IF; Pavlova VA; Slasten EV; Abramova VV; Belov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):62-67. PubMed ID: 31626220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of cortexin in acute and recovery periodes of hemispheric ischemic stroke].
    Belova LA; Mashin VV; Abramova VV; Proshin AN; Ovsjannikova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):38-42. PubMed ID: 27845314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the effectiveness of neuroprotective therapy in restoring motor function in patients during the acute period of ischemic stroke].
    Minina YD; Zakharov AV; Poverennova IE; Androfagina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):44-50. PubMed ID: 34693688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of Korteksin in acute period of hemispheric ischemic stroke].
    Belova LA; Mashin VV; Abramova VV; Slastyon EY; Belov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(7):30-34. PubMed ID: 30132453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The experience of using cellex in treatment of patients with acute ischemic stroke].
    Gaponenko IA; Bakhareva EV; Zolotareva ZM; Zuev GI; Rozhdestvenskiy AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):43-47. PubMed ID: 29863691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cognitive impairment in patients poluchennym ischemic stroke in the acute and early recovery periods in the process of neuroprotection low-dose drug cortexin].
    Belova LA; Mashin VV; Abramova VV; Proshin AN; Ovsjannikova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8 Pt 2):40-43. PubMed ID: 27905386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EFFECT OF CORTEXIN ON THE QUALITY OF LIFE IN THE EARLY REHABILITATIVE PERIOD AFTER HEMISPHERIC ISCHEMIC STROKE].
    Belova LA; Mashin VV; Abramova VV; Proshin AN; Ovsyannikova AN
    Klin Med (Mosk); 2016; 94(2):138-43. PubMed ID: 27459764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An open clinical trial of cortexin in treatment of brain ischemia].
    Mashin VV; Belova LA; Chaplanova OI; Khusnullina AF; Manasian AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):49-52. PubMed ID: 25403301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellex in the therapy of patients with complex and central apnea in the early recovery period of ischemic stroke].
    Lavrick SY; Borisov AS; Shprakh VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):29-32. PubMed ID: 33908229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke].
    Belova LA; Mashin VV; Proshin AN; Ovsyannicova AN; Kostishko BB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):51-58. PubMed ID: 29053121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study)].
    Mashin VV; Belova LA; Kotova EY; Dolgova DR; Statenina AP; Belyaeva YK; Dergacheva AS; Israfilova RR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12):34-41. PubMed ID: 38147380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurotrophic therapy in the treatment of a comorbid patient with cerebrovascular pathology and diabetes mellitus].
    Kurushina OV; Barulin AE; Chernovolenko EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8):112-119. PubMed ID: 36036412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of the drug Cellex for the treatment of patients with cognitive impairment with chronic cerebral ischemia - results of a multicenter randomized double-blind placebo-controlled clinical trial].
    Shchukin IA; Koltsov IA; Fidler MS; Chubykin VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):108-116. PubMed ID: 37315249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New opportunities for neuroprotective therapy of patients in the acute and early recovery period of ischemic stroke].
    Tanashyan MM; Raskurazhev AA; Zaslavskaya KI; Kuznetsova PI; Merkulova IY
    Ter Arkh; 2022 Aug; 94(6):748-755. PubMed ID: 36286852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study)].
    Fedin AI; Belskaya GN; Kurushina OV; Kovalchuk VV; Starych EV; Chichanovskaya LV; Baranova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):35-42. PubMed ID: 30335070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy and pharmacoeconomic characteristics of the neuroprotection with low doses of cortexin in the treatment of acute ischemic stroke].
    Aliferova VM; Dadasheva MN; Doronin BM; Kovalenko AV; Lokshtanova TM; Martynov MIu; Meshkova KS; Salimov KA; Stakhovskaia LV; Chefranova ZhIu; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):41-6. PubMed ID: 24874316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of complex rehabilitation in post-stroke patients treated with cellex].
    Volodeeva EA; Samarina SI; Glotova ME; Kurtin AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):34-41. PubMed ID: 32929922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of metabolic treatment in the early recovery period of patients with ischemic stroke].
    Poltavskaya TS; Bazhenov VA; Volojanin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):49-53. PubMed ID: 32307430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of recovery of cognitive deficit in patients in the early recovery period of ischemic stroke].
    Kotov SV; Borisova VA; Slyunkova EV; Isakova EV; Kiselev AV; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):26-32. PubMed ID: 34932282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.